
hVimentin | |
Type |
Mouse Anti Human Monoclonal Antibody |
Introduction | Vimentin expression in human malignant glioma cells depends on cellular density, algorithms of drug delivery and chemo/radio treatment. Vimentin and detyrosinated microtubules provide structural support for the extensive microtentacles observed in detached tumor cells and a mechanism to promote successful metastatic spread. Primary colorectal carcinomas display aberrant expression of vimentin, and have activated Notch and TGFbeta signaling pathways. Vimentin is a strong arterial substrate for transglutaminases. Transglutaminase-mediated vimentin dimerization results in a novel unifying pathway by which vasodilatory and remodeling responses may be regulated. Ablation of vimentin expression inhibits migration and invasion of colon and breast cancer cell lines. |
Clone | hVimentin |
Immunogen | hVimentin |
Ig Subclass | Mouse IgG1 |
Purification Method | Protein A column. |
Usage | FOR LABORATORY RESEARCH USE ONLY. |
Applications | For intra-cellular staining, use 5-10µl/1,000,000 cells. Wash twice with PBS/Azide before adding the appropriate amount of secondary fluorescent reagent. |
Cat No.: | PTAB1450032 |
Product Name: | hVimentin |
Type: | Protein |
Property: | |
Origin: | |
Source: | |
Application: | For intra-cellular staining, use 5-10µl/1,000,000 cells. Wash twice with PBS/Azide before adding the |
Formulation: | |
Purity: | |
Storage: | |
Limitation: | |
Note: |